Adamera Minerals completes underground inspection at Talisman tungsten mine in Washington State
Bitget2026/10/01 15:30- Adamera completed an underground inspection of its 100%-owned Talisman tungsten mine in Washington to evaluate re-entry for exploration.
- JDS Mining found no immediate safety impediments; only minor ground support expected; no dewatering needs identified; ventilation judged adequate.
- Chalcopyrite, scheelite, and sphalerite were observed at the portal and adit; the previously mined stope was not entered.
- A 3D magnetic inversion model indicates the magnetic body extends beyond 200 meters depth versus roughly 30 meters previously mined.
- Warrant expiry for 20,150,000 $0.12 warrants was accelerated to Oct. 21, 2026; full exercise would raise $2,418,000.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Rocket Lab’s stock falls as quarterly loss exceeds expectations
BUZZ-Take-Two shares rise after raising annual revenue and profit forecasts
Itaúsa Q3 2026 recurring net profit rises 25% to R$ 5.06 billion year-on-year
The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.
NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.
Crypto prices
More
